{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:26:35Z","timestamp":1770830795408,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jns.2016.11.078","type":"journal-article","created":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T17:45:39Z","timestamp":1480787139000},"page":"318-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Serum antibodies targeting neurons of the monoaminergic systems in Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"372","author":[{"given":"Claudia","family":"Rink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"G\u00f6rtzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger W.","family":"Veh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-7976","authenticated-orcid":false,"given":"Harald","family":"Pr\u00fcss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jns.2016.11.078_bb0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol."},{"issue":"4","key":"10.1016\/j.jns.2016.11.078_bb0010","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.jns.2016.11.078_bb0015","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barre syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"Pt 12","key":"10.1016\/j.jns.2016.11.078_bb0020","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.jns.2016.11.078_bb0025","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1093\/brain\/awq372","article-title":"Neurofascin as target of autoantibodies in Guillain-Barre syndrome","volume":"134","author":"Pr\u00fcss","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jns.2016.11.078_bb0030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jnnp.2007.123943","article-title":"Immune responses to myelin proteins in Guillain-Barre syndrome","volume":"79","author":"Makowska","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.jns.2016.11.078_bb0035","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00415-008-0815-9","article-title":"Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barre syndrome","volume":"255","author":"Wanschitz","year":"2008","journal-title":"J. Neurol."},{"issue":"6\u20137","key":"10.1016\/j.jns.2016.11.078_bb0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/08916930412331279840","article-title":"Anti-astrocyte autoantibodies in Guillain-Barre syndrome\u2014possible involvement in the pathophysiology of a psychosyndrome?","volume":"37","author":"G\u00f6rtzen","year":"2004","journal-title":"Autoimmunity"},{"issue":"Pt 9","key":"10.1016\/j.jns.2016.11.078_bb0045","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barre syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jns.2016.11.078_bb0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jns.2016.11.078_bb0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0033-3182(83)73205-6","article-title":"Guillain-Barre syndrome: psychosocial aspects of management","volume":"24","author":"Eisendrath","year":"1983","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.jns.2016.11.078_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000047956","article-title":"Psychotic symptoms and emotional distress in patients with Guillain-Barre syndrome","volume":"47","author":"Weiss","year":"2002","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2016.11.078_bb0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","article-title":"Imaging of autoimmune encephalitis - relevance for clinical practice and hippocampal function","volume":"309","author":"Heine","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2016.11.078_bb0070","series-title":"Principles of Neural Science","author":"Kandel","year":"1991"},{"issue":"4","key":"10.1016\/j.jns.2016.11.078_bb0075","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0306-4522(83)90108-2","article-title":"Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6)","volume":"10","author":"Mesulam","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2016.11.078_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1990.tb16870.x","article-title":"Anatomy of the serotonergic system","volume":"600","author":"T\u00f6rk","year":"1990","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.jns.2016.11.078_bb0085","first-page":"1","article-title":"Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons","volume":"232","author":"Dahlstr\u00f6m","year":"1964","journal-title":"Acta Physiol Scand Suppl."},{"key":"10.1016\/j.jns.2016.11.078_bb0090","series-title":"Catecholaminergic Neurons. The Human Nervous System","author":"Pearson","year":"1990"},{"key":"10.1016\/j.jns.2016.11.078_bb0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jns.2016.11.078_bb0100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0926-6410(00)00012-4","article-title":"Increases in cortical acetylcholine release during sustained attention performance in rats","volume":"9","author":"Himmelheber","year":"2000","journal-title":"Brain Res. Cogn. Brain Res."},{"issue":"7","key":"10.1016\/j.jns.2016.11.078_bb0105","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1523\/JNEUROSCI.22-07-02843.2002","article-title":"The physiological role of 5-HT2A receptors in working memory","volume":"22","author":"Williams","year":"2002","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.jns.2016.11.078_bb0110","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1474-4422(13)70118-2","article-title":"New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease","volume":"12","author":"Calabresi","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2016.11.078_bb0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.jns.2016.11.078_bb0120","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain-Barre syndrome","volume":"62","author":"Hughes","year":"2005","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2016.11.078_bb0125","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/mus.880171004","article-title":"Autonomic involvement in Guillain-Barre syndrome: a review","volume":"17","author":"Zochodne","year":"1994","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.jns.2016.11.078_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.21913","article-title":"Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems","volume":"513","author":"Fetissov","year":"2009","journal-title":"J. Comp. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16307821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16307821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T09:13:21Z","timestamp":1531473201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16307821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":26,"alternative-id":["S0022510X16307821"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.11.078","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum antibodies targeting neurons of the monoaminergic systems in Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.11.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}